QHP Capital, L.P.

QHP Capital, L.P. provides investment supervisory services to pooled, privately offered investment vehicles and their institutional investors, offering long‑term private equity and equity‑related investments. The adviser reports approximately $4.57 billion in discretionary assets under management and focuses on technology‑enabled service companies in the biopharmaceutical, life sciences, and healthcare sectors.

The firm pursues primarily control‑oriented investments in revenue‑generating companies using a thematic, research‑driven sourcing and due‑diligence process and provides structuring, negotiation, board representation, monitoring, and disposition services on behalf of its funds. QHP also operates co‑investment vehicles and implements individualized allocation and side‑letter arrangements; investment advice is provided to the pooled vehicles rather than directly to individual investors.

QHP’s ADV materials disclose several features that are less common among peers: the brochure traces the firm and its predecessors to 2010, documents the use of placement agents during fundraising, and indicates the use of third‑party endorsements, testimonials, and predecessor performance in its marketing. The firm’s ownership ties to Sir Dennis Gillings and its explicit disclosure of potential portfolio‑company remuneration arrangements (for example, monitoring and advisory fees) and detailed allocation and valuation practices are additional governance and conflict‑management points prospective investors should consider.